{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:26:25Z","timestamp":1787005585047,"version":"build-2736575974"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"34","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,9,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Renal cell carcinoma (RCC) affects over 435,000 people worldwide each year and remains a significant cause of cancer mortality. Aberrant activation of pathways such as mTORC1 is frequently observed in RCC, yet the mechanisms by which mTORC1 contributes to tumor development remain poorly understood. The lack of suitable animal models has limited progress in uncovering these mechanisms and advancing targeted treatments. Here, we performed single-cell transcriptomic, proteomic, and metabolomic profiling of kidneys from mice with embryonic\n                    <jats:italic>Tsc2<\/jats:italic>\n                    deletion at E17.5, which revealed a distinct tumor cell population characterized by intercalated cell signatures, co-expression of\n                    <jats:italic>Foxi1<\/jats:italic>\n                    and\n                    <jats:italic>Rhcg<\/jats:italic>\n                    , and hyperactivated mTORC1. These lesions closely resemble human chromophobe renal cell carcinoma (ChRCC), a subtype of RCC. The tumors show marked upregulation of the immune checkpoint molecule B7-H3. Mechanistically, the transcription factor NRF1 is elevated in\n                    <jats:italic>Tsc2<\/jats:italic>\n                    -deficient lesions and drives B7-H3 expression in tumor cells. In human specimens, B7-H3 is broadly expressed in both classical and sarcomatoid ChRCC and correlates with hallmark markers FOXI1, MUC2, and HEPACAM2. Strikingly, B7-H3 deletion in mice suppresses\n                    <jats:italic>Tsc2<\/jats:italic>\n                    loss-driven cystic and tumor formation, restores amino acid metabolism, and attenuates aminoacyl-tRNA biosynthesis and proteasome activity. Collectively, these findings identify B7-H3 as a functional driver of\n                    <jats:italic>Tsc2<\/jats:italic>\n                    -mediated ChRCC and a promising therapeutic target in TSC-associated renal tumors.\n                  <\/jats:p>","DOI":"10.1038\/s41388-026-03891-w","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:53:18Z","timestamp":1784555598000},"page":"3525-3540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["mTORC1 activation induces B7-H3-dependent metabolic reprogramming in renal cell carcinoma (RCC)"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1561-7605","authenticated-orcid":false,"given":"Keying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2801-604X","authenticated-orcid":false,"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damir","family":"Khabibullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8288-7212","authenticated-orcid":false,"given":"Michel","family":"Alchoueiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Daou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Asara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7978-6699","authenticated-orcid":false,"given":"Elizabeth P.","family":"Henske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9685-6572","authenticated-orcid":false,"given":"Heng-Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"3891_CR1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch H, Amin MB, Berney DM, Comp\u00e9rat EM, Gill AJ, Hartmann A, et al. The 2022 World Health Organization classification of tumours of the urinary system and male genital organs\u2014Part A: renal, penile, and testicular tumours. Eur Urol. 2022;82:458\u201368.","journal-title":"Eur Urol"},{"key":"3891_CR2","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.ccell.2023.07.006","volume":"41","author":"EP Henske","year":"2023","unstructured":"Henske EP, Cheng L, Hakimi AA, Choueiri TK, Braun DA. Chromophobe renal cell carcinoma. Cancer Cell. 2023;41:1383\u20138.","journal-title":"Cancer Cell"},{"key":"3891_CR3","doi-asserted-by":"publisher","first-page":"14087","DOI":"10.1073\/pnas.1211502109","volume":"109","author":"TC Larman","year":"2012","unstructured":"Larman TC, DePalma SR, Hadjipanayis AG, Protopopov A, Zhang J, Gabriel SB, et al. Cancer Genome Atlas Research Network Spectrum of somatic mitochondrial mutations in five cancers. Proc Natl Acad Sci USA. 2012;109:14087\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3891_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","volume":"26","author":"CF Davis","year":"2014","unstructured":"Davis CF, Ricketts C, Wang M, Yang L, Cherniack AD, Shen H, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014;26:319.","journal-title":"Cancer Cell"},{"key":"3891_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","volume":"23","author":"CJ Ricketts","year":"2018","unstructured":"Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, et al. The Cancer Genome Atlas comprehensive molecular characterization of renal cell carcinoma. Cell Rep. 2018;23:313\u201326.e5.","journal-title":"Cell Rep"},{"key":"3891_CR6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2122840119","volume":"119","author":"L Zhang","year":"2022","unstructured":"Zhang L, Hobeika CS, Khabibullin D, Yu D, Filippakis H, Alchoueiry M, et al. Hypersensitivity to ferroptosis in chromophobe RCC is mediated by a glutathione metabolic dependency and cystine import via solute carrier family 7 member 11. Proc Natl Acad Sci USA. 2022;119:e2122840119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3891_CR7","doi-asserted-by":"publisher","first-page":"E6274","DOI":"10.1073\/pnas.1710849115","volume":"115","author":"C Priolo","year":"2018","unstructured":"Priolo C, Khabibullin D, Reznik E, Filippakis H, Og\u00f3rek B, Kavanagh TR, et al. Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma. Proc Natl Acad Sci USA. 2018;115:E6274\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3891_CR8","first-page":"393","volume":"11","author":"B Zbar","year":"2002","unstructured":"Zbar B, Alvord WG, Glenn G, Turner M, Pavlovich CP, Schmidt L, et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dub\u00e9 syndrome. Cancer Epidemiol Biomark Prev. 2002;11:393\u2013400.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3891_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.35","volume":"2","author":"EP Henske","year":"2016","unstructured":"Henske EP, J\u00f3\u017awiak S, Kingswood JC, Sampson JR, Thiele EA. Tuberous sclerosis complex. Nat Rev Dis Primers. 2016;2:16035.","journal-title":"Nat Rev Dis Primers"},{"key":"3891_CR10","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41581-018-0059-6","volume":"14","author":"HC Lam","year":"2018","unstructured":"Lam HC, Siroky BJ, Henske EP. Renal disease in tuberous sclerosis complex: pathogenesis and therapy. Nat Rev Nephrol. 2018;14:704\u201316.","journal-title":"Nat Rev Nephrol"},{"key":"3891_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","volume":"38","author":"P Yang","year":"2014","unstructured":"Yang P, Cornejo KM, Sadow PM, Cheng L, Wang M, Xiao Y, et al. Renal cell carcinoma in tuberous sclerosis complex. Am J Surg Pathol. 2014;38:895\u2013909.","journal-title":"Am J Surg Pathol"},{"key":"3891_CR12","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","volume":"38","author":"J Guo","year":"2014","unstructured":"Guo J, Tretiakova MS, Troxell ML, Osunkoya AO, Fadare O, Sangoi AR, et al. Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients. Am J Surg Pathol. 2014;38:1457\u201367.","journal-title":"Am J Surg Pathol"},{"key":"3891_CR13","doi-asserted-by":"publisher","first-page":"18722","DOI":"10.1073\/pnas.0908853106","volume":"106","author":"Y Hasumi","year":"2009","unstructured":"Hasumi Y, Baba M, Ajima R, Hasumi H, Valera VA, Klein ME, et al. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci USA. 2009;106:18722\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3891_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1136\/jmg.2009.072009","volume":"47","author":"V Hudon","year":"2010","unstructured":"Hudon V, Sabourin S, Dydensborg AB, Kottis V, Ghazi A, Paquet M, et al. Renal tumour suppressor function of the Birt-Hogg-Dub\u00e9 syndrome gene product folliculin. J Med Genet. 2010;47:182\u20139.","journal-title":"J Med Genet"},{"key":"3891_CR15","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/ki.2015.177","volume":"88","author":"J Chen","year":"2015","unstructured":"Chen J, Huang D, Rubera I, Futami K, Wang P, Zickert P, et al. Disruption of tubular Flcn expression as a mouse model for renal tumor induction. Kidney Int. 2015;88:1057\u201369.","journal-title":"Kidney Int"},{"key":"3891_CR16","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/onc.2009.14","volume":"28","author":"TR Hartman","year":"2009","unstructured":"Hartman TR, Nicolas E, Klein-Szanto A, Al-Saleem T, Cash TP, Simon MC, et al. The role of the Birt-Hogg-Dub\u00e9 protein in mTOR activation and renal tumorigenesis. Oncogene. 2009;28:1594\u2013604.","journal-title":"Oncogene"},{"key":"3891_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1172\/JCI7319","volume":"104","author":"H Onda","year":"1999","unstructured":"Onda H, Lueck A, Marks PW, Warren HB, Kwiatkowski DJ. Tsc2(+\/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Investig. 1999;104:687\u201395.","journal-title":"J Clin Investig"},{"key":"3891_CR18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nm.1865","volume":"14","author":"M Traykova-Brauch","year":"2008","unstructured":"Traykova-Brauch M, Sch\u00f6nig K, Greiner O, Miloud T, Jauch A, Bode M, et al. An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice. Nat Med. 2008;14:979\u201384.","journal-title":"Nat Med"},{"key":"3891_CR19","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1084\/jem.20140341","volume":"211","author":"N Liang","year":"2014","unstructured":"Liang N, Zhang C, Dill P, Panasyuk G, Pion D, Koka V, et al. Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. J Exp Med. 2014;211:2249\u201363.","journal-title":"J Exp Med"},{"key":"3891_CR20","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1016\/j.ajpath.2016.08.013","volume":"186","author":"S Ren","year":"2016","unstructured":"Ren S, Luo Y, Chen H, Warburton D, Lam HC, Wang LL, et al. Inactivation of Tsc2 in mesoderm-derived cells causes polycystic kidney lesions and impairs lung alveolarization. Am J Pathol. 2016;186:3261\u201372.","journal-title":"Am J Pathol"},{"key":"3891_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01514-3","volume":"8","author":"AF Gon\u00e7alves","year":"2017","unstructured":"Gon\u00e7alves AF, Adlesic M, Brandt S, Hejhal T, Harlander S, Sommer L, et al. Evidence of renal angiomyolipoma neoplastic stem cells arising from renal epithelial cells. Nat Commun. 2017;8:1466.","journal-title":"Nat Commun"},{"key":"3891_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44229-4","volume":"15","author":"N Alesi","year":"2024","unstructured":"Alesi N, Khabibullin D, Rosenthal DM, Akl EW, Cory PM, Alchoueiry M, et al. TFEB drives mTORC1 hyperactivation and kidney disease in tuberous sclerosis complex. Nat Commun. 2024;15:406.","journal-title":"Nat Commun"},{"key":"3891_CR23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.celrep.2018.06.106","volume":"24","author":"L Drusian","year":"2018","unstructured":"Drusian L, Nigro EA, Mannella V, Pagliarini R, Pema M, Costa ASH, et al. mTORC1 upregulation leads to accumulation of the oncometabolite fumarate in a mouse model of renal cell carcinoma. Cell Rep. 2018;24:1093\u2013104.e6.","journal-title":"Cell Rep"},{"key":"3891_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","volume":"30","author":"X He","year":"2020","unstructured":"He X, Xu C. Immune checkpoint signaling and cancer immunotherapy. Cell Res. 2020;30:660\u20139.","journal-title":"Cell Res"},{"key":"3891_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.immuni.2024.01.013","volume":"57","author":"KP Burke","year":"2024","unstructured":"Burke KP, Chaudhri A, Freeman GJ, Sharpe AH. The B7:CD28 family and friends: Unraveling coinhibitory interactions. Immunity. 2024;57:223\u201344.","journal-title":"Immunity"},{"key":"3891_CR26","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41423-023-01019-8","volume":"20","author":"MC Pulanco","year":"2023","unstructured":"Pulanco MC, Madsen AT, Tanwar A, Corrigan DT, Zang X. Recent advancements in the B7\/CD28 immune checkpoint families: new biology and clinical therapeutic strategies. Cell Mol Immunol. 2023;20:694\u2013713.","journal-title":"Cell Mol Immunol"},{"key":"3891_CR27","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.7150\/ijbs.41105","volume":"16","author":"S Yang","year":"2020","unstructured":"Yang S, Wei W, Zhao Q. B7-H3, a checkpoint molecule, as a target for cancer immunotherapy. Int J Biol Sci. 2020;16:1767\u201373.","journal-title":"Int J Biol Sci"},{"key":"3891_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13045-022-01364-7","volume":"15","author":"B Zhao","year":"2022","unstructured":"Zhao B, Li H, Xia Y, Wang Y, Wang Y, Shi Y, et al. Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy. J Hematol Oncol. 2022;15:153.","journal-title":"J Hematol Oncol"},{"key":"3891_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46735-5","volume":"15","author":"M Cheng","year":"2024","unstructured":"Cheng M, Chen S, Li K, Wang G, Xiong G, Ling R, et al. CD276-dependent efferocytosis by tumor-associated macrophages promotes immune evasion in bladder cancer. Nat Commun. 2024;15:2818.","journal-title":"Nat Commun"},{"key":"3891_CR30","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.7150\/thno.105947","volume":"15","author":"Z Ma","year":"2025","unstructured":"Ma Z, Yang J, Jia W, Li L, Li Y, Hu J, et al. Histone lactylation-driven B7-H3 expression promotes tumor immune evasion. Theranostics. 2025;15:2338\u201359.","journal-title":"Theranostics"},{"key":"3891_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36881-7","volume":"14","author":"H-J Liu","year":"2023","unstructured":"Liu H-J, Du H, Khabibullin D, Zarei M, Wei K, Freeman GJ, et al. mTORC1 upregulates B7-H3\/CD276 to inhibit antitumor T cells and drive tumor immune evasion. Nat Commun. 2023;14:1214.","journal-title":"Nat Commun"},{"key":"3891_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccell.2017.03.005","volume":"31","author":"S Seaman","year":"2017","unstructured":"Seaman S, Zhu Z, Saha S, Zhang XM, Yang MY, Hilton MB, et al. Eradication of tumors through simultaneous ablation of CD276\/B7-H3-positive tumor cells and tumor vasculature. Cancer Cell. 2017;31:501\u201315.e8.","journal-title":"Cancer Cell"},{"key":"3891_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.eururo.2022.09.004","volume":"83","author":"C Guo","year":"2023","unstructured":"Guo C, Figueiredo I, Gurel B, Neeb A, Seed G, Crespo M, et al. B7-H3 as a therapeutic target in advanced prostate cancer. Eur Urol. 2023;83:224\u201338.","journal-title":"Eur Urol"},{"key":"3891_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1549-6","volume":"10","author":"T Shi","year":"2019","unstructured":"Shi T, Ma Y, Cao L, Zhan S, Xu Y, Fu F, et al. B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2. Cell Death Dis. 2019;10:308.","journal-title":"Cell Death Dis"},{"key":"3891_CR35","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41375-018-0331-6","volume":"33","author":"L Lin","year":"2019","unstructured":"Lin L, Cao L, Liu Y, Wang K, Zhang X, Qin X, et al. B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src\/STAT3 and c-Cbl-mediated degradation of SOCS3. Leukemia. 2019;33:1475\u201386.","journal-title":"Leukemia"},{"key":"3891_CR36","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.stem.2021.04.011","volume":"28","author":"C Wang","year":"2021","unstructured":"Wang C, Li Y, Jia L, Kim JK, Li J, Deng P, et al. CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance. Cell Stem Cell. 2021;28:1597\u2013613.e7.","journal-title":"Cell Stem Cell"},{"key":"3891_CR37","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1158\/1078-0432.CCR-17-2852","volume":"24","author":"K Yonesaka","year":"2018","unstructured":"Yonesaka K, Haratani K, Takamura S, Sakai H, Kato R, Takegawa N, et al. B7-H3 negatively modulates CTL-mediated cancer immunity. Clin Cancer Res. 2018;24:2653\u201364.","journal-title":"Clin Cancer Res"},{"key":"3891_CR38","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-20-2540","volume":"27","author":"EI Lichtman","year":"2021","unstructured":"Lichtman EI, Du H, Shou P, Song F, Suzuki K, Ahn S, et al. Preclinical evaluation of B7-H3-specific chimeric antigen receptor T cells for the treatment of acute myeloid leukemia. Clin Cancer Res. 2021;27:3141\u201353.","journal-title":"Clin Cancer Res"},{"key":"3891_CR39","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41591-020-0821-8","volume":"26","author":"J Theruvath","year":"2020","unstructured":"Theruvath J, Sotillo E, Mount CW, Graef CM, Delaidelli A, Heitzeneder S, et al. Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid\/rhabdoid tumors. Nat Med. 2020;26:712\u20139.","journal-title":"Nat Med"},{"key":"3891_CR40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41423-019-0305-2","volume":"17","author":"D Cai","year":"2020","unstructured":"Cai D, Li J, Liu D, Hong S, Qiao Q, Sun Q, et al. Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy. Cell Mol Immunol. 2020;17:227\u201336.","journal-title":"Cell Mol Immunol"},{"key":"3891_CR41","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/ni967","volume":"4","author":"W-K Suh","year":"2003","unstructured":"Suh W-K, Gajewska BU, Okada H, Gronski MA, Bertram EM, Dawicki W, et al. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat Immunol. 2003;4:899\u2013906.","journal-title":"Nat Immunol"},{"key":"3891_CR42","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/cr.2017.90","volume":"27","author":"Y Lee","year":"2017","unstructured":"Lee Y, Martin-Orozco N, Zheng P, Li J, Zhang P, Tan H, et al. Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function. Cell Res. 2017;27:1034\u201345.","journal-title":"Cell Res"},{"key":"3891_CR43","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.immuni.2022.03.008","volume":"55","author":"K Peuker","year":"2022","unstructured":"Peuker K, Strigli A, Tauriello DVF, Hendricks A, von Sch\u00f6nfels W, Burmeister G, et al. Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3- and B7H4-dependent anti-tumor immunity in colorectal cancer. Immunity. 2022;55:701\u201317.e7.","journal-title":"Immunity"},{"key":"3891_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110737","volume":"109","author":"R Wu","year":"2023","unstructured":"Wu R, Zhang Y, Xu X, You Q, Yu C, Wang W, et al. Exosomal B7-H3 facilitates colorectal cancer angiogenesis and metastasis through AKT1\/mTOR\/VEGFA pathway. Cell Signal. 2023;109:110737.","journal-title":"Cell Signal"},{"key":"3891_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2252-3","volume":"11","author":"R Wang","year":"2020","unstructured":"Wang R, Ma Y, Zhan S, Zhang G, Cao L, Zhang X, et al. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-\u03baB pathway to induce VEGFA expression. Cell Death Dis. 2020;11:55.","journal-title":"Cell Death Dis"},{"key":"3891_CR46","doi-asserted-by":"publisher","first-page":"e010924","DOI":"10.1136\/jitc-2024-010924","volume":"13","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Qian Z, Wang C, Wu D, Liu L, Ning X, et al. Targeting B7-H3 inhibition-induced activation of fatty acid synthesis boosts anti-B7-H3 immunotherapy in triple-negative breast cancer. J Immunother Cancer. 2025;13:e010924.","journal-title":"J Immunother Cancer"},{"key":"3891_CR47","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1158\/0008-5472.CAN-15-1538","volume":"76","author":"S Lim","year":"2016","unstructured":"Lim S, Liu H, Madeira da Silva L, Arora R, Liu Z, Phillips JB, et al. Immunoregulatory protein B7-H3 reprograms glucose metabolism in cancer cells by ROS-mediated stabilization of HIF1\u03b1. Cancer Res. 2016;76:2231\u201342.","journal-title":"Cancer Res"},{"key":"3891_CR48","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05541","volume":"445","author":"A Ventura","year":"2007","unstructured":"Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, et al. Restoration of p53 function leads to tumour regression in vivo. Nature. 2007;445:661\u20135.","journal-title":"Nature"},{"key":"3891_CR49","doi-asserted-by":"publisher","first-page":"15629","DOI":"10.1073\/pnas.95.26.15629","volume":"95","author":"G Rennebeck","year":"1998","unstructured":"Rennebeck G, Kleymenova EV, Anderson R, Yeung RS, Artzt K, Walker CL. Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proc Natl Acad Sci USA. 1998;95:15629\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3891_CR50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2001;68:64\u201380.","journal-title":"Am J Hum Genet"},{"key":"3891_CR51","doi-asserted-by":"publisher","first-page":"8762","DOI":"10.1073\/pnas.151033798","volume":"98","author":"T Kobayashi","year":"2001","unstructured":"Kobayashi T, Minowa O, Sugitani Y, Takai S, Mitani H, Kobayashi E, et al. A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice. Proc Natl Acad Sci USA. 2001;98:8762\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3891_CR52","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, et al. Comprehensive integration of single-cell data. Cell. 2019;177:1888\u2013902.e21.","journal-title":"Cell"},{"key":"3891_CR53","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.devcel.2019.10.005","volume":"51","author":"A Ransick","year":"2019","unstructured":"Ransick A, Lindstr\u00f6m NO, Liu J, Zhu Q, Guo J-J, Alvarado GF, et al. Single-cell profiling reveals sex, lineage, and regional diversity in the mouse kidney. Dev Cell. 2019;51:399\u2013413.e7.","journal-title":"Dev Cell"},{"key":"3891_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33:1\u201322.","journal-title":"J Stat Softw"},{"key":"3891_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street K, Risso D, Fletcher RB, Das D, Ngai J, Yosef N, et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genom. 2018;19:477.","journal-title":"BMC Genom"},{"key":"3891_CR56","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1530\/ERC-15-0505","volume":"23","author":"H Prizant","year":"2016","unstructured":"Prizant H, Taya M, Lerman I, Light A, Sen A, Mitra S, et al. Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis model. Endocr Relat Cancer. 2016;23:265\u201380.","journal-title":"Endocr Relat Cancer"},{"key":"3891_CR57","doi-asserted-by":"publisher","unstructured":"Li GX, Chen L, Hsiao Y, Mannan R, Zhang Y, Luo J, et al. Comprehensive proteogenomic characterization of rare kidney tumors. Cell Rep Med. 2024;5. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101547.","DOI":"10.1016\/j.xcrm.2024.101547"},{"key":"3891_CR58","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.celrep.2017.07.043","volume":"20","author":"D Lindgren","year":"2017","unstructured":"Lindgren D, Eriksson P, Krawczyk K, Nilsson H, Hansson J, Veerla S, et al. Cell-type-specific gene programs of the normal human nephron define kidney cancer subtypes. Cell Rep. 2017;20:1476\u201389.","journal-title":"Cell Rep"},{"key":"3891_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35833-5","volume":"14","author":"AH Nassar","year":"2023","unstructured":"Nassar AH, Abou Alaiwi S, Baca SC, Adib E, Corona RI, Seo J-H, et al. Epigenomic charting and functional annotation of risk loci in renal cell carcinoma. Nat Commun. 2023;14:346.","journal-title":"Nat Commun"},{"key":"3891_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104463","volume":"25","author":"R Jikuya","year":"2022","unstructured":"Jikuya R, Murakami K, Nishiyama A, Kato I, Furuya M, Nakabayashi J, et al. Single-cell transcriptomes underscore genetically distinct tumor characteristics and microenvironment for hereditary kidney cancers. iScience. 2022;25:104463.","journal-title":"iScience"},{"key":"3891_CR61","doi-asserted-by":"publisher","first-page":"D721","DOI":"10.1093\/nar\/gky900","volume":"47","author":"X Zhang","year":"2019","unstructured":"Zhang X, Lan Y, Xu J, Quan F, Zhao E, Deng C, et al. CellMarker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 2019;47:D721\u20138.","journal-title":"Nucleic Acids Res"},{"key":"3891_CR62","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1097\/PAS.0b013e3181831e68","volume":"32","author":"MB Amin","year":"2008","unstructured":"Amin MB, Paner GP, Alvarado-Cabrero I, Young AN, Stricker HJ, Lyles RH, et al. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol. 2008;32:1822\u201334.","journal-title":"Am J Surg Pathol"},{"key":"3891_CR63","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1464-410X.2011.10690.x","volume":"110","author":"A Volpe","year":"2012","unstructured":"Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, et al. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. BJU Int. 2012;110:76\u201383.","journal-title":"BJU Int"},{"key":"3891_CR64","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.clgc.2019.06.011","volume":"17","author":"J Casuscelli","year":"2019","unstructured":"Casuscelli J, Becerra MF, Seier K, Manley BJ, Benfante N, Redzematovic A, et al. Chromophobe renal cell carcinoma: results from a large single-institution series. Clin Genitourin Cancer. 2019;17:373\u20139.e4.","journal-title":"Clin Genitourin Cancer"},{"key":"3891_CR65","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.176743","volume":"9","author":"P Kapur","year":"2024","unstructured":"Kapur P, Zhong H, Le D, Mukhopadhyay R, Miyata J, Carrillo D, et al. Molecular underpinnings of dedifferentiation and aggressiveness in chromophobe renal cell carcinoma. JCI Insight. 2024;9:e176743.","journal-title":"JCI Insight"},{"key":"3891_CR66","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2022","unstructured":"Castro-Mondragon JA, Riudavets-Puig R, Rauluseviciute I, Lemma RB, Turchi L, Blanc-Mathieu R, et al. JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2022;50:D165\u201373.","journal-title":"Nucleic Acids Res"},{"key":"3891_CR67","doi-asserted-by":"publisher","unstructured":"Li H, Amaral A, Vidotto T, Woo J, Liu HB, Oliveira LD, et al. mTOR-mediated upregulation of B7-H3 in MiT\/TFE translocation renal cell carcinoma. J Pathol. 2026;268. https:\/\/doi.org\/10.1002\/path.6490.","DOI":"10.1002\/path.6490"},{"key":"3891_CR68","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1200\/JCO-25-00234","volume":"43","author":"C Labaki","year":"2025","unstructured":"Labaki C, Saad E, Madsen KN, Hobeika C, Bi K, Alchoueiry M, et al. Tumor-intrinsic and microenvironmental determinants of impaired antitumor immunity in chromophobe renal cell carcinoma. J Clin Oncol. 2025;43:2639\u201354.","journal-title":"J Clin Oncol"},{"key":"3891_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217259","volume":"604","author":"C Zhang","year":"2024","unstructured":"Zhang C, Gou X, Lai G, Li K, Zhu X, Liu N, et al. Single-nucleus sequencing unveils heterogeneity in renal cell carcinomas microenvironment: insights into pathogenic origins and treatment-responsive cellular subgroups. Cancer Lett. 2024;604:217259.","journal-title":"Cancer Lett"},{"key":"3891_CR70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2103240118","volume":"118","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Narayanan SP, Mannan R, Raskind G, Wang X, Vats P, et al. Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response. Proc Natl Acad Sci USA. 2021;118:e2103240118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3891_CR71","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1126\/science.aar2131","volume":"360","author":"J Park","year":"2018","unstructured":"Park J, Shrestha R, Qiu C, Kondo A, Huang S, Werth M, et al. Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease. Science. 2018;360:758\u201363.","journal-title":"Science"},{"key":"3891_CR72","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1172\/JCI40221","volume":"120","author":"M Karbowniczek","year":"2010","unstructured":"Karbowniczek M, Zitserman D, Khabibullin D, Hartman T, Yu J, Morrison T, et al. The evolutionarily conserved TSC\/Rheb pathway activates Notch in tuberous sclerosis complex and Drosophila external sensory organ development. J Clin Investig. 2010;120:93\u2013102.","journal-title":"J Clin Investig"},{"key":"3891_CR73","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.24265","volume":"6","author":"M Werth","year":"2017","unstructured":"Werth M, Schmidt-Ott KM, Leete T, Qiu A, Hinze C, Viltard M, et al. Transcription factor TFCP2L1 patterns cells in the mouse kidney collecting ducts. eLife. 2017;6:e24265.","journal-title":"eLife"},{"key":"3891_CR74","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1158\/1078-0432.CCR-08-0536","volume":"14","author":"PL Crispen","year":"2008","unstructured":"Crispen PL, Sheinin Y, Roth TJ, Lohse CM, Kuntz SM, Frigola X, et al. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res. 2008;14:5150\u20137.","journal-title":"Clin Cancer Res"},{"key":"3891_CR75","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13000-023-01320-0","volume":"18","author":"JH Lee","year":"2023","unstructured":"Lee JH, Kim YJ, Ryu HW, Shin SW, Kim EJ, Shin SH, et al. B7-H3 expression is associated with high PD-L1 expression in clear cell renal cell carcinoma and predicts poor prognosis. Diagn Pathol. 2023;18:36.","journal-title":"Diagn Pathol"},{"key":"3891_CR76","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1158\/0008-5472.CAN-20-1998","volume":"80","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Rabien A, Buschow R, Amtislavskiy V, Busch J, Kilic E, et al. Endocytosis-mediated replenishment of amino acids favors cancer cell proliferation and survival in chromophobe renal cell carcinoma. Cancer Res. 2020;80:5491\u2013501.","journal-title":"Cancer Res"},{"key":"3891_CR77","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ncb847","volume":"4","author":"X Gao","year":"2002","unstructured":"Gao X, Zhang Y, Arrazola P, Hino O, Kobayashi T, Yeung RS, et al. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol. 2002;4:699\u2013704.","journal-title":"Nat Cell Biol"},{"key":"3891_CR78","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.devcel.2020.08.006","volume":"55","author":"S Yang","year":"2020","unstructured":"Yang S, Zhang Y, Ting C-Y, Bettedi L, Kim K, Ghaniam E, et al. The Rag GTPase regulates the dynamic behavior of TSC downstream of both amino acid and growth factor restriction. Dev Cell. 2020;55:272\u201388.e5.","journal-title":"Dev Cell"},{"key":"3891_CR79","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.cell.2014.01.024","volume":"156","author":"C Demetriades","year":"2014","unstructured":"Demetriades C, Doumpas N, Teleman AA. Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2. Cell. 2014;156:786\u201399.","journal-title":"Cell"},{"key":"3891_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35795-8","volume":"14","author":"JM Lee","year":"2023","unstructured":"Lee JM, Hammar\u00e9n HM, Savitski MM, Baek SH. Control of protein stability by post-translational modifications. Nat Commun. 2023;14:201.","journal-title":"Nat Commun"},{"key":"3891_CR81","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1152\/physiol.00026.2024","volume":"39","author":"N Alesi","year":"2024","unstructured":"Alesi N, Asrani K, Lotan TL, Henske EP. The spectrum of renal \u2018TFEopathies\u2019: flipping the mTOR switch in renal tumorigenesis. Physiology. 2024;39:347\u201359.","journal-title":"Physiology"},{"key":"3891_CR82","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nature13492","volume":"513","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Nicholatos J, Dreier JR, Ricoult SJH, Widenmaier SB, Hotamisligil GS, et al. Coordinated regulation of protein synthesis and degradation by mTORC1. Nature. 2014;513:440\u20133.","journal-title":"Nature"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03891-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03891-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03891-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:02:55Z","timestamp":1787004175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03891-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":82,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2026,9,8]]}},"alternative-id":["3891"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03891-w","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}